For research use only. Not for therapeutic Use.
Domvanalimab (AB154) is an anti-TIGIT humanized monoclonal antibody. Domvanalimab binds human TIGIT9 and blocks the TIGIT-CD155 interaction. Domvanalimab can be used in research of cancer[1].
| Catalog Number | I041529 |
| CAS Number | 2368219-35-4 |
| Purity | ≥95% |
| Reference | [1]. Dolgin E. Antibody engineers seek optimal drug targeting TIGIT checkpoint. Nat Biotechnol. 2020 Sep;38(9):1007-1009. |
